Redmile as of March 31, 2014
Portfolio Holdings for Redmile
Redmile holds 55 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actavis | 6.0 | $51M | 246k | 205.85 | |
| Hca Holdings (HCA) | 5.4 | $46M | 873k | 52.50 | |
| Agilent Technologies Inc C ommon (A) | 5.1 | $43M | 773k | 55.92 | |
| Valeant Pharmaceuticals Int | 4.7 | $39M | 297k | 131.83 | |
| Clovis Oncology | 4.2 | $36M | 513k | 69.27 | |
| Tenet Healthcare Corporation (THC) | 4.0 | $34M | 790k | 42.81 | |
| Globus Med Inc cl a (GMED) | 3.4 | $28M | 1.1M | 26.59 | |
| HeartWare International | 3.2 | $27M | 292k | 93.78 | |
| Castlight Health | 3.0 | $25M | 1.2M | 21.22 | |
| Rite Aid Corporation | 2.8 | $24M | 3.8M | 6.27 | |
| Healthways | 2.8 | $23M | 1.4M | 17.14 | |
| Array BioPharma | 2.7 | $23M | 4.9M | 4.70 | |
| Bristol Myers Squibb (BMY) | 2.6 | $22M | 419k | 51.95 | |
| Insulet Corporation (PODD) | 2.6 | $22M | 457k | 47.42 | |
| Prothena (PRTA) | 2.5 | $21M | 560k | 38.31 | |
| Chimerix (CMRX) | 2.4 | $20M | 895k | 22.84 | |
| NuVasive | 2.4 | $20M | 521k | 38.41 | |
| Jazz Pharmaceuticals (JAZZ) | 2.4 | $20M | 143k | 138.68 | |
| Gw Pharmaceuticals Plc ads | 2.3 | $19M | 324k | 59.37 | |
| Intra Cellular Therapies (ITCI) | 2.2 | $18M | 1.0M | 18.18 | |
| Puma Biotechnology (PBYI) | 2.1 | $18M | 172k | 104.14 | |
| Amicus Therapeutics (FOLD) | 2.1 | $18M | 8.5M | 2.07 | |
| Kythera Biopharmaceuticals I | 2.1 | $18M | 443k | 39.76 | |
| Intercept Pharmaceuticals In | 2.0 | $17M | 51k | 329.80 | |
| Align Technology (ALGN) | 1.8 | $15M | 295k | 51.79 | |
| Celldex Therapeutics | 1.8 | $15M | 864k | 17.67 | |
| Accuray Incorporated (ARAY) | 1.7 | $14M | 1.5M | 9.60 | |
| NxStage Medical | 1.6 | $14M | 1.1M | 12.74 | |
| Receptos | 1.6 | $13M | 311k | 41.94 | |
| Oxford Immunotec Global | 1.5 | $13M | 625k | 20.07 | |
| Cardiovascular Systems | 1.5 | $12M | 392k | 31.79 | |
| Portola Pharmaceuticals | 1.4 | $12M | 452k | 25.90 | |
| Nanostring Technologies (NSTGQ) | 1.3 | $11M | 528k | 20.65 | |
| Endologix | 1.2 | $10M | 795k | 12.87 | |
| Achaogen | 1.2 | $10M | 654k | 15.46 | |
| Model N (MODN) | 1.0 | $8.6M | 854k | 10.11 | |
| Flexion Therapeutics | 1.0 | $8.1M | 493k | 16.45 | |
| XOMA CORP Common equity shares | 0.9 | $7.9M | 1.5M | 5.21 | |
| Derma Sciences | 0.9 | $7.6M | 598k | 12.68 | |
| Inogen (INGN) | 0.9 | $7.6M | 461k | 16.51 | |
| BioSpecifics Technologies | 0.8 | $7.0M | 272k | 25.92 | |
| Ignyta | 0.6 | $5.0M | 600k | 8.30 | |
| Geron Corporation (GERN) | 0.5 | $4.4M | 2.1M | 2.08 | |
| Ambit Bioscience | 0.4 | $3.4M | 368k | 9.12 | |
| Vocera Communications | 0.3 | $2.8M | 173k | 16.33 | |
| Cerus Corporation (CERS) | 0.3 | $2.8M | 586k | 4.80 | |
| Genocea Biosciences | 0.3 | $2.3M | 125k | 18.19 | |
| Halozyme Therapeutics (HALO) | 0.1 | $815k | 64k | 12.70 | |
| Ophthotech | 0.1 | $692k | 19k | 35.72 | |
| Cynosure | 0.1 | $586k | 20k | 29.30 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $379k | 6.5k | 58.31 | |
| Allergan | 0.0 | $222k | 1.8k | 124.30 | |
| Market Vectors Etf Tr Biotech | 0.0 | $292k | 3.2k | 91.02 | |
| Affymetrix | 0.0 | $96k | 14k | 7.11 | |
| Sunesis Pharmaceuticals | 0.0 | $66k | 10k | 6.60 |
